Brief: Sio Gene Therapies Announces Fiscal Year 2021 Year-End Financial Results
14/06/2022 12:28
June 14 (Reuters) - Sio Gene Therapies Inc SIOX.O :
* SIO GENE THERAPIES ANNOUNCES FISCAL YEAR 2021 YEAR-END
FINANCIAL
RESULTS
* Q4 LOSS PER SHARE $0.18
Source text for Eikon: ID:nGNX1shLGy
Further company coverage: SIOX.O
Recent news on Sio Gene Therapies
See all newsBrief: Sio Gene Therapies Inc - On March 14, Got Notice That Nasdaq Has Determined That Company's Common Stock Will Be Delisted From Nasdaq Capital Market
Brief: Sio Gene Therapies Announces Fiscal Third Quarter 2022 Financial Results
Brief: Sio Gene Therapies Inc. Announces Board Approval Of Plan Of Complete Liquidation, Dissolution
Brief: Sio Gene Therapies Announces Second Quarter Financial Results
Brief: Sio Gene Therapies Announces Fiscal First Quarter 2022 Financial Results